Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ankit Pansara

Diagnostic Radiology New Orleans, LA Medical Doctor

NPI 1790975019 CMS profile 36374

1514 Jefferson Hwy, Radiology Department, New Orleans, LA 70121

Open in the dashboard

General payments

$28,481

496 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$60,218 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ankit Pansara of New Orleans, LA is reported in the CMS Open Payments database as having received $28,481 across 496 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $60,218 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,125 116
2024 General $2,573 69
2023 General $5,666 68
2022 General $10,012 102
2021 General $2,619 57
2020 General $802 22
2019 General $3,685 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ankit Pansara
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Ankit Pansara were reported at $3,125. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Ankit Pansara Diagnostic Radiology median Middle half National median
2019 $3,685 $108 $29–$318 $163
2020 $802 $65 $21–$252 $114
2021 $2,619 $92 $24–$292 $132
2022 $10,012 $104 $29–$294 $149
2023 $5,666 $110 $29–$337 $160
2024 $2,573 $113 $30–$356 $164
2025 $3,125 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $8,936 66 payments
  2. Penumbra, Inc. $7,354 64 payments
  3. Inari Medical, Inc. $3,050 41 payments
  4. Imperative Care, INc $1,949 91 payments
  5. Medtronic, Inc. $1,434 55 payments
  6. DePuy Synthes Sales Inc. $1,121 29 payments
  7. Argon Medical Devices, Inc. $622 7 payments
  8. MicroVention, Inc. $617 23 payments
  9. AngioDynamics, Inc. $536 13 payments
  10. Boston Scientific Corporation $365 11 payments
  11. Other $2,498 96 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,493 482 payments
  2. Consulting Fee $6,400 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,600 2 payments
  4. Travel and Lodging $1,989 9 payments
Products named General payments · program years 2019–2025
  1. SPINEJACK $5,243 10 payments
  2. FLOWTRIEVER CATHETER, S $3,461 44 payments
  3. PCD $3,200 2 payments
  4. AVAFLEX $3,200 2 payments
  5. AUTOPLEX $3,200 2 payments
  6. CT THROMBECTOMY SYSTEM KIT $2,967 40 payments
  7. Indigo System $2,931 44 payments
  8. Penumbra System $2,530 3 payments
  9. VERTEPORT $1,200 1 payment
  10. Smart Coil $1,200 1 payment
  11. Other $12,916 437 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 201 billing codes

Paid by Medicare

$84,185

Of which drugs: $604

Medicare patients

943

Average age 76

Services billed

6,279

544 women, 399 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 63%
Ischemic heart disease 53%
Chronic kidney disease 45%
Depression 41%
Diabetes 40%
Heart failure 35%
Atrial fibrillation 35%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 41 4,235 $443

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

496 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record